|
|
|
Jan Mueller-Berghaus is a
certified paediatrician and holds a M.D. He worked as a paediatrician
at the paediatric hospital of the University of Cologne, Germany, from
1991 to 1998. Subsequently he gained experience as a researcher and
immunologist during a stay in the USA (University of Pittsburgh,
Department of Surgery) and as a clinician/scientist at the German
Cancer Research Center (DKFZ, Clinical Cooperation Unit Skin Cancer),
Heidelberg from 1998 to 2005.
He joined the Paul-Ehrlich-Institut in 2005 as a clinical assessor and
is currently Head of the Monoclonal and Polyclonal Antibodies section.
The Paul-Ehrlich-Institut is the German Federal Agency for Sera and
Vaccines and is involved in all aspects of German and European
marketing authorisation as well as clinical trial authorisation.
|
